This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Editas Medicine, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Christopher Borges: Innovator in Cancer Immunotherapy
Introduction
Christopher Borges is a notable inventor based in Reading, MA (US). He has made significant contributions to the field of cancer immunotherapy through his innovative work. His research focuses on utilizing CRISPR technology to develop new methods for treating cancer.
Latest Patents
Christopher Borges holds a patent for "Crispr-CPF1-related methods, compositions and components for cancer immunotherapy." This patent encompasses CRISPR/Cpf1-related compositions and methods aimed at the treatment of cancer. His work in this area is groundbreaking and has the potential to change the landscape of cancer treatment.
Career Highlights
Borges is currently employed at Editas Medicine, Inc., a company that specializes in gene editing and therapeutic solutions. His role at Editas Medicine allows him to further his research and contribute to the development of innovative therapies.
Collaborations
Throughout his career, Christopher Borges has collaborated with esteemed colleagues, including Gordon Grant Welstead and Hariharan Jayaram. These collaborations have enhanced his research and expanded the impact of his work in the field of cancer immunotherapy.
Conclusion
Christopher Borges is a pioneering inventor whose work in CRISPR technology is paving the way for new cancer treatments. His contributions to the field are invaluable and highlight the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile